Dr. Alessio Fasano, director of the Center for Celiac Research and Treatment at Mass General for Children, answers FAQs regarding school reopening during the COVID-19 pandemic. He discusses specific challenges for students with celiac disease, and acknowledges the steep learning curve of COVID-19 research.
In March of 2020, the World Health Organization (WHO) declared coronavirus disease 2019 (COVID-19) a pandemic. As the rapid spread of the novel virus continues to impact communities worldwide, there has been understandable concern from the celiac community regarding celiac disease susceptibility and risk level. In this short video, Dr. Alessio Fasano shares his medical perspective on the virus as it pertains to people with celiac disease and gluten-related disorders.
Dr. Alessio Fasano, from the Center for Celiac Research and Treatment at MGfC, answers frequently asked questions from the celiac community regarding celiac disease and the COVID-19 health crisis. He also presents a brief survey opportunity for diagnosed celiac patients, as part of an effort to collect preliminary data for research.
As part of an effort to collect preliminary data for research efforts, and to enhance patient care and safety, Dr. Alessio Fasano and the Center for Celiac Research and Treatment team at MGfC present a survey for diagnosed celiac disease patients. This survey, powered by REDCap (a secure data collection platform), is brief and anonymous. The survey answers will be used to deepen our understanding of health outcomes for patients with celiac disease. Anonymous survey for DIAGNOSED celiac disease patients.